These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 38431408

  • 1. Hyaluronic acid/dextran-based polymeric micelles co-delivering ursolic acid and doxorubicin to mitochondria for potentiating chemotherapy in MDR cancer.
    Guo Y, Yang X, Zhang Y, Luo F, Yang J, Zhang X, Mi J, Xie Y.
    Carbohydr Polym; 2024 May 15; 332():121897. PubMed ID: 38431408
    [Abstract] [Full Text] [Related]

  • 2. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
    Qiu L, Qiao M, Chen Q, Tian C, Long M, Wang M, Li Z, Hu W, Li G, Cheng L, Cheng L, Hu H, Zhao X, Chen D.
    Biomaterials; 2014 Dec 15; 35(37):9877-9887. PubMed ID: 25201738
    [Abstract] [Full Text] [Related]

  • 3. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN, Guo NN, Guo WW, Huang-Fu MY, Vakili MR, Chen JJ, Xu WH, Wei QC, Han M, Lavasanifar A, Gao JQ.
    Acta Pharmacol Sin; 2018 Oct 15; 39(10):1681-1692. PubMed ID: 29849132
    [Abstract] [Full Text] [Related]

  • 4. Mitochondria-Targeting Polyprodrugs to Overcome the Drug Resistance of Cancer Cells by Self-Amplified Oxidation-Triggered Drug Release.
    Mukerabigwi JF, Tang R, Cao Y, Mohammed F, Zhou Q, Zhou M, Ge Z.
    Bioconjug Chem; 2023 Feb 15; 34(2):377-391. PubMed ID: 36716444
    [Abstract] [Full Text] [Related]

  • 5. Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance.
    Qiu L, Xu J, Ahmed KS, Zhu M, Zhang Y, Long M, Chen W, Fang W, Zhang H, Chen J.
    Acta Biomater; 2022 Mar 01; 140():686-699. PubMed ID: 34875359
    [Abstract] [Full Text] [Related]

  • 6. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin.
    Wang J, Ma W, Guo Q, Li Y, Hu Z, Zhu Z, Wang X, Zhao Y, Chai X, Tu P.
    Int J Nanomedicine; 2016 Mar 01; 11():5851-5870. PubMed ID: 27853369
    [Abstract] [Full Text] [Related]

  • 7. Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance.
    Zhong XC, Shi MH, Liu HN, Chen JJ, Wang TT, Lin MT, Zhang ZT, Zhou Y, Lu YY, Xu WH, Gao JQ, Xu DH, Han M, Chen YD.
    Pharm Dev Technol; 2021 Jan 01; 26(1):21-29. PubMed ID: 33070673
    [Abstract] [Full Text] [Related]

  • 8. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
    Wang J, Li Y, Wang L, Wang X, Tu P.
    Drug Deliv; 2018 Nov 01; 25(1):330-340. PubMed ID: 29350064
    [Abstract] [Full Text] [Related]

  • 9. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
    Liu Y, Sun J, Lian H, Cao W, Wang Y, He Z.
    J Pharm Sci; 2014 May 01; 103(5):1538-47. PubMed ID: 24619562
    [Abstract] [Full Text] [Related]

  • 10. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
    Zhou Y, Wang S, Ying X, Wang Y, Geng P, Deng A, Yu Z.
    Int J Nanomedicine; 2017 May 01; 12():6153-6168. PubMed ID: 28883726
    [Abstract] [Full Text] [Related]

  • 11. Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles.
    Liu S, Li R, Qian J, Sun J, Li G, Shen J, Xie Y.
    Mol Pharm; 2020 Apr 06; 17(4):1415-1427. PubMed ID: 32159961
    [Abstract] [Full Text] [Related]

  • 12. A multifunctional nano-delivery system enhances the chemo-co-phototherapy of tumor multidrug resistance via mitochondrial-targeting and inhibiting P-glycoprotein-mediated efflux.
    Zhao R, Ning X, Wang M, Yu A, Wang Y.
    J Mater Chem B; 2021 Nov 17; 9(44):9174-9182. PubMed ID: 34698329
    [Abstract] [Full Text] [Related]

  • 13. Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.
    Liu HN, Guo NN, Wang TT, Guo WW, Lin MT, Huang-Fu MY, Vakili MR, Xu WH, Chen JJ, Wei QC, Han M, Lavasanifar A, Gao JQ.
    Mol Pharm; 2018 Mar 05; 15(3):882-891. PubMed ID: 29357260
    [Abstract] [Full Text] [Related]

  • 14. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P, Yu H, Guo C, Cui Z, Chen X, Yin Q, Zhang P, Yang X, Cui H, Li Y.
    Acta Biomater; 2015 Mar 05; 14():115-24. PubMed ID: 25498306
    [Abstract] [Full Text] [Related]

  • 15. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
    Hou L, Tian C, Chen D, Yuan Y, Yan Y, Huang Q, Zhang H, Zhang Z.
    Eur J Pharm Sci; 2019 Dec 01; 140():105071. PubMed ID: 31525433
    [Abstract] [Full Text] [Related]

  • 16. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH, Lee JS, Bae JW, Choi JH, Lee Y, Son JY, Park KD.
    Int J Pharm; 2015 Nov 10; 495(1):329-335. PubMed ID: 26325307
    [Abstract] [Full Text] [Related]

  • 17. Mitochondria-targeted vitamin E succinate delivery for reversal of multidrug resistance.
    Liang L, Peng Y, Qiu L.
    J Control Release; 2021 Sep 10; 337():117-131. PubMed ID: 34274383
    [Abstract] [Full Text] [Related]

  • 18. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer.
    Mao J, Qiu L, Ge L, Zhou J, Ji Q, Yang Y, Long M, Wang D, Teng L, Chen J.
    Biomed Pharmacother; 2021 Feb 10; 134():111108. PubMed ID: 33341670
    [Abstract] [Full Text] [Related]

  • 19. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J, Zhao X, Chen Q, Yin X, Xin X, Li K, Qiao M, Hu H, Chen D, Zhao X.
    Acta Biomater; 2017 Mar 01; 50():381-395. PubMed ID: 27956367
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y, Zhou C, Wei S, Yang T, Lan Y, Cao A, Yang J, Hou Y.
    Colloids Surf B Biointerfaces; 2018 Oct 01; 170():330-340. PubMed ID: 29936386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.